B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes
Reversing diabetes with CRISPR and patient-derived stem cells | Fierce Biotech
CRISPR-Cas9 successfully reverses obesity in mice
Target gene activation via CRISPR/Cas9 used to treat type 1 diabetes, muscular dystrophy, and acute kidney disease in mouse models : r/science
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
Strategies for durable β cell replacement in type 1 diabetes | Science
CRISPR Therapeutics and ViaCyte, Inc. Announce First
Type-2 Diabetes and Gene Therapy: The Promise of CRISPR Gene Therapy in type-2 Diabetes Mellitus - Open Access Pub
News: First CRISPR Therapy for Type 1 Diabetes Set to Enter Clinical Trial - CRISPR Medicine
Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes - YouTube
Can CRISPR Therapeutics (CRSP) and ViaCyte CURE Type 1 Diabetes? | VCTX210 - YouTube
Forscher heilen Diabetes bei Mäusen mit genkorrigierten menschlichen...
ViaCyte | Regenerative Medicine Therapies for Diabetes
ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
Can CRISPR gene therapy help cure diabetes? - New West Physicians : New West Physicians | Healthcare Providers
CRISPR, ViaCyte begin dosing in phase 1 trial of gene-edited therapy for type 1 diabetes | Seeking Alpha
New CRISPR/Cas9 Technique to Potentially Cure Type 1 Diabetes Mellitus - European Medical Journal
CRISPR-based genome editing in primary human pancreatic islet cells | Nature Communications
Salk scientists modify CRISPR to epigenetically treat diabetes, kidney disease, muscular dystrophy - Salk Institute for Biological Studies
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review | PLOS ONE
CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination - eBioMedicine
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
